Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 20, 2004
[Mechanism of the intestinal dysmotility in the inflammatory bowel diseases: possible involvement of muscularis resident macrophages]Hiroshi Ozaki, Kazuya Kinoshita, Masatoshi Hori
Inflammopharmacology|November 2, 2005
Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contractionHiroshi Ozaki, Masatoshi Hori, Kazuya Kinoshita, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 21, 2003
Decrease in activity of smooth muscle L-type Ca2+ channels and its reversal by NF-kappaB inhibitors in Crohn's colitis modelKazuya Kinoshita, Koichi Sato, Masatoshi Hori, et al.
European Journal of Pharmacology|November 19, 2009
Halichlorine is a novel L-type Ca(2+) channel inhibitor isolated from the marine sponge Halichondria okadai KadotaYoshiki Tsubosaka, Takahisa Murata, Kazuya Kinoshita, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2005
Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertensionTakahisa Murata, Kazuya Kinoshita, Masatoshi Hori, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2007
Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526)Keiichi Ito, Kazuya Kinoshita, Atsuyuki Tomizawa, et al.
Pageof 4